Efficacy and safety of poly ADP-ribose polymerase inhibitors (PARPis) in extensive-stage small-cell lung cancer (ES-SCLC) treatment: a systematic review and meta-analysis. - Cheng CC; Ma LJ; Pang XM; Huang TS; Wang MF; Xu JY; Wang RQ; Chen X; Sun K; Zhao WX; Yan M; Wang P (Journal of thoracic disease, 2025)